Log in

Relevant bibliographies by topics / Postmenopausal Phase

Contents

Journal articles
Books
Book chapters
Conference papers

Academic literature on the topic 'Postmenopausal Phase'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Postmenopausal Phase.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Postmenopausal Phase"

1

Krunić, Jelena, Irena Mladenović, and Nikola Stojanović. "Dental pulp pain in young and postmenopausal women: a pilot study." Stomatoloski glasnik Srbije 63, no. 3 (2016): 125–32. http://dx.doi.org/10.1515/sdj-2016-0013.

Full text

Abstract:

Abstract Introduction This pilot study was aimed to compare pulpal pain provoked by electrical and thermal (cold) stimuli in healthy young women during various phases of menstrual cycle and postmenopausal women. Material and methods The study included 20 regularly menstruating healthy women and 20 postmenopausal women. Electrical (electrical pulp tester) and cold (refrigerant spray) stimuli were performed on mandibular central incisors, twice in regularly menstruating (menstrual and luteal phases) and once in postmenopausal women. Results were expressed as pain threshold values for electrical

APA, Harvard, Vancouver, ISO, and other styles

2

Dr., Kavita Tanwar, Deepali Jain Dr., Meenakshi Samariya Dr., Narendra Mahawar Dr., and Ajay Sharma Dr. "Gynecological morbidity and co-morbidity in postmenopausal women: A descriptive study." International Multispeciality Journal of Health 3, no. 7 (2017): 244–51. https://doi.org/10.5281/zenodo.837973.

Full text

Abstract:

<strong><em>Abstract—</em></strong><em>Menopause is very crucial phase of woman’s life. There are many health problems that are associated with postmenopausal phase. So this present study was conducted on 215 postmenopausal women with the aim to find out gynecological problems associated with postmenopausal period. This study observed that 70.5% women experienced hot flushes and sweating, 65.5% had insomnia, 37.6% complained of headache. Decreased libido was observed in 80.9% women and 54.4% reported dyspareunia. 78.1% women complained of backache. Joint pain was complained by 52.5% of women.

APA, Harvard, Vancouver, ISO, and other styles

3

Plexico, Laura W., Mary J. Sandage, Heidi A. Kluess, Ana M. Franco-Watkins, and Leslie E. Neidert. "Blood Plasma Hormone–Level Influence on Vocal Function." Journal of Speech, Language, and Hearing Research 63, no. 5 (2020): 1376–86. http://dx.doi.org/10.1044/2020_jslhr-19-00224.

Full text

Abstract:

Purpose This preliminary study examined the influence of menstrual cycle phase and hormone levels on acoustic measurements of vocal function in reproductive and postmenopausal females. Mean fundamental frequency (f0), speaking fundamental frequency (Sf0), and cepstral peak prominence (CPP) were evaluated. It was hypothesized that Sf0 and CPP would be lower during the luteal and ischemic phases of the menstrual cycle. Group differences with lower values in postmenopausal females and greater variability in the reproductive females were also hypothesized. Method A mixed factorial analysis of vari

APA, Harvard, Vancouver, ISO, and other styles

4

Temyingyong, Nathathai, Nut Koonrungsesomboon, Nutthiya Hanprasertpong, Mingkwan Na Takuathung, and Supanimit Teekachunhatean. "Effect of Short-Course Oral Ciprofloxacin on Isoflavone Pharmacokinetics following Soy Milk Ingestion in Healthy Postmenopausal Women." Evidence-Based Complementary and Alternative Medicine 2019 (April 11, 2019): 1–10. http://dx.doi.org/10.1155/2019/7192326.

Full text

Abstract:

Soy isoflavones have several potential benefits related to postmenopausal health. Isoflavone glycosides, found predominantly in nonfermented soy products, e.g., soy milk, require conversion by gut microbiota to their respective bioavailable aglycones prior to absorption into portal circulation. Use of short-course oral ciprofloxacin for the treatment of acute uncomplicated cystitis, the incidence of which is increasing among postmenopausal women, might adversely affect gut microbiota. The objective of this one-group pre-post treatment study was to determine the effect of short-course oral cipr

APA, Harvard, Vancouver, ISO, and other styles

5

Patel, Rita R., Mary J. Sandage, Heidi Kluess, and Laura W. Plexico. "High-Speed Characterization of Vocal Fold Vibrations in Normally Cycling and Postmenopausal Women: Randomized Double-Blind Analyses." Journal of Speech, Language, and Hearing Research 64, no. 6 (2021): 1869–88. http://dx.doi.org/10.1044/2021_jslhr-20-00706.

Full text

Abstract:

Purpose The aim of this study was to examine the influence of menstrual cycle phases (follicular, ovulatory, luteal, and ischemic) and hormone levels (estradiol, testosterone, progesterone, and neuropeptide Y) on vocal fold vibrations in reproductive and postmenopausal women. Method Glottal area waveforms were extracted from high-speed videoendoscopy during sustained phonation, inhalation phonation, and voice onset/offset in the reproductive ( n = 15) and postmenopausal ( n = 13) groups. Linear mixed-model analysis was conducted to evaluate hormone levels and high-speed videoendoscopy outcome

APA, Harvard, Vancouver, ISO, and other styles

6

Zhao, Tiping, and Guifen He. "A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer." Tumori Journal 74, no. 1 (1988): 53–56. http://dx.doi.org/10.1177/030089168807400109.

Full text

Abstract:

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

APA, Harvard, Vancouver, ISO, and other styles

7

Saphner, T., A. B. Troxel, D. C. Tormey, et al. "Phase II study of goserelin for patients with postmenopausal metastatic breast cancer." Journal of Clinical Oncology 11, no. 8 (1993): 1529–35. http://dx.doi.org/10.1200/jco.1993.11.8.1529.

Full text

Abstract:

PURPOSE To determine the response rate of postmenopausal breast cancer patients to the gonadotropin-releasing hormone (GN-RH) agonist, Zoladex (goserelin; ICI Pharma, Wilmington, DE). PATIENTS AND METHODS A multi-institutional single-agent trial in postmenopausal patients was conducted. Serum levels of follicle-stimulating hormone (FSH), testosterone, and estradiol were requested before and after Zoladex treatment. RESULTS For estrogen receptor-positive (ER+) patients, the response rate was 11%, with one complete response (CR) and three partial responses (PRs) among 36 eligible patients. Respo

APA, Harvard, Vancouver, ISO, and other styles

8

EMMANUEL, A. V., M. A. KAMM, and R. W. BEARD. "Reproducible assessment of vaginal and rectal mucosal and skin blood flow: laser doppler fluximetry of the pelvic microcirculation." Clinical Science 98, no. 2 (2000): 201–7. http://dx.doi.org/10.1042/cs0980201.

Full text

Abstract:

Pelvic venous congestion is a common cause of chronic pelvic pain in women of reproductive age. Although this condition represents a functional disturbance of the pelvic circulation which is related to the menstrual cycle, its aetiology remains unknown. Indirect techniques demonstrate that the vasoconstrictive reflex response of the microcirculation of the foot to a rise in venous pressure is attenuated throughout the menstrual cycle. We wished to develop a simple and non-invasive direct measure of pelvic blood flow to aid diagnosis of this condition. Laser doppler blood flux measurements of t

APA, Harvard, Vancouver, ISO, and other styles

9

Cheng, Min-Yi, Yi-Fang Zhang, Ci-Qiu Yang, et al. "Phase II trial with letrozole as neoadjuvant treatment in postmenopausal and premenopausal patients with highly endocrine responsive operable breast cancer." Journal of Clinical Oncology 35, no. 15_suppl (2017): e12125-e12125. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12125.

Full text

Abstract:

e12125 Background: Neoadjuvant endocrine therapy (NET)is effective in postmenopausal patients with breast cancers expressing oestrogen receptor. However, the therapeutic benefit of NET in premenopausal population is not fully characterized. We aimed to assess the efficacy and safety of endocrine therapy between the postmenopausal and premenopausal patients with highly endocrine responsiveoperable breast cancer for primary systemic therapy. Methods: Previously untreated patients with operable breast cancer and highly endocrine responsive breast cancer (ER/PR≥50% and Her2-) were recruited. Patie

APA, Harvard, Vancouver, ISO, and other styles

10

Mady, Essam A., Ezz El-Din H. Ramadan, and Alaa A. Ossman. "Sex Steroid Hormones in Serum and Tissue of Benign and Malignant Breast Tumor Patients." Disease Markers 16, no. 3-4 (2000): 151–57. http://dx.doi.org/10.1155/2000/305940.

Full text

Abstract:

The ability of breast tumors to synthesize sex steroid hormones is well recognized and their local production is thought to play a role in breast cancer development and growth. The aim of this study was to estimate local intra-tumoral and circulating levels of Estrone (E1), Estrone Sulfate (E1S), Estradiol (E2), Estriol (E3), and Testosterone (T) in 33 pre- and postmenopausal women with primary breast cancer in comparison to 12 pre- and postmenopausal women with benign breast tumors. The mean levels of the studied sex hormones were higher in serum and tumor tissue of breast cancer women than t

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Postmenopausal Phase"

1

Khan, A. A. Cytohormonal Profile of a Female from Birth to Postmenopausal Phase: A Review. CBS Publishers & Distributors, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Postmenopausal Phase"

1

Vaidya, Rama, Namyata Pathak, Ashwini Raut, and Deepak Patkar. "Sarcopenia at Menopause: Is it Phase-specific or Multi-modal?" In Postmenopausal Osteoporosis: Basic and Clinical Concepts. Jaypee Brothers Medical Publishers (P) Ltd., 2013. http://dx.doi.org/10.5005/jp/books/11789_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Segal, Sheldon J., and Luigi Mastroianni. "Why do women have menopause?" In Hormone Use in Menopause & Male Andropause. Oxford University PressNew York, NY, 2003. http://dx.doi.org/10.1093/oso/9780195159745.003.0001.

Full text

Abstract:

Abstract Menopause is the result of an inevitable decline in ovarian function. The term usually denotes the completion of a full year without a menstrual period. As menopause approaches, the ovaries decrease in size as virtually all the egg-containing ovarian follicles are lost due to a process called atresia. Estrogen production diminishes, and cycles tend to become shorter and more erratic. Menopause follows this last phase of the life cycle of the ovary which starts early in fetal life when the gland mobilizes the resources it will later need to assure egg and hormone production throughout

APA, Harvard, Vancouver, ISO, and other styles

3

Downes, Martin, Kyoo Kim, Marcelo Graziano Custodio, Igor Solev, Tommaso Simoncini, and Qi Yu. "The Impact of Estrogen Deficiency Symptoms on Health-Related Quality of Life in Menopausal-Aged Women in China." In Women's Health Around the Globe [Working Title]. IntechOpen, 2025. https://doi.org/10.5772/intechopen.1008518.

Full text

Abstract:

Menopausal symptoms are a critical health issue as they can have a substantial detrimental effect on women’s physical and mental health and substantially impair health-related quality of life (HRQoL). Vasomotor symptoms (VMS) such as hot flushes, sweating, sleep disturbances, irritability, anxiety, and depression are often considered the cardinal symptoms of menopause. Among Chinese women of menopausal age, the symptom burden is high, with hot flushes/sweating, sleep disorders, mood disorders, and fatigue reported to be prevalent. In this chapter, we describe the available data on the burden o

APA, Harvard, Vancouver, ISO, and other styles

4

Rees, Margaret C. P. "Physiology of the normal menopause and end-points of treatment." In Hormone replacement therapy. Oxford University PressNew York, NY, 1999. http://dx.doi.org/10.1093/oso/9780192629562.003.0002.

Full text

Abstract:

Abstract Overall, the mean age of menopause is 51 years, which means that with the increased longevity of the population most women in Western societies will spend 30 or more years in the post-menopausal state (McKinlay et al. 1992; Luoto et al. 1994). Various definitions are used to describe the menopause (McKinlay et al. 1992; Richardson 1993): the menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity the menopause transition describes the period prior to the final menstrual period with the endocrinological, biological, and clinical features

APA, Harvard, Vancouver, ISO, and other styles

5

Amala, M., and D. Nagasen. "ADVANCEMENT OF THE FEMALE REPRODUCTIVE PHASES CORRELATED WITH POSTMENOPAUSAL COMPLICATIONS INTENSIFICATION: CURRENT APPROACHES TO THE PREVENTION AND TREATMENT." In Futuristic Trends in Pharmacy & Nursing Volume 2 Book 25. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2023. http://dx.doi.org/10.58532/v2bs25p1ch2.

Full text

Abstract:

Women go through menopause naturally as they age. Many women transition into menopause with few or no symptoms, while others experience severe or even incapacitating symptoms. When female gynaecologist Trotula of Salerno stated that "there are older women who put forth blood matter especially when menopause approaches them" in the 11th century, we had a very different notion of the menopause. However, little is understood regarding the effects of menopause on women's mental health, particularly in the case of severe and persistent conditions like schizophrenia. Many postmenopausal women get vu

APA, Harvard, Vancouver, ISO, and other styles

6

Baker, Fiona C., Rena Wang, and Helen S. Driver. "Sex Differences in Sleep." In The Oxford Handbook of Sleep and Sleep Disorders, 2nd ed. Oxford University Press, 2025. https://doi.org/10.1093/oxfordhb/9780197602751.013.9.

Full text

Abstract:

Abstract In this chapter the authors discuss sex differences in sleep behavior, sleep structure, and aspects of three sleep disorders. Women report a greater need for sleep and sleep longer than men, as determined from self-report as well as actigraphy and wearable sleep trackers, although this difference is heavily influenced by family and work responsibilities. Women are also more likely to have earlier bedtimes and a morning chronotype, which may in part be a consequence of their phase-advanced circadian rhythms and shorter circadian period compared with men. Women are more likely than men

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Postmenopausal Phase"

1

Hortobagyi, GN, M. Piccart, H. Rugo, et al. "S3-7: Everolimus for Postmenopausal Women with Advanced Breast Cancer: Updated Results of the BOLERO-2 Phase III Trial." In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-s3-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Coombes, R., P. Schmid, N. Isambert, et al. "A Phase I Dose Escalation Study of Steroid Sulfatase Inhibitor BN83495/STX64 in Postmenopausal Women with ER Positive Breast Cancer." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-4097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Aristarco, Valentina, Sara Gandini, Harriet Joahnsson, et al. "Abstract 3670: A randomized, placebo-controlled, phase II, presurgical biomarker trial of celecoxib or exemestane in postmenopausal breast cancer patients." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3670.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hurvitz, S., M. Martin, M. Fernández Abad, et al. "Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-s4-06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ma, Cynthia X., Jingqin Luo, Michael Naughton, et al. "Abstract PD5-6: A phase I study of BKM120 and fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer." In Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-pd5-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ma, CX, J. Wang, J. Luo, et al. "Abstract PD1-4: A phase I study of BKM120 and fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-pd1-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pritchard, K., J. Rolski, Z. Pápai, et al. "A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-4095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hattersley, G., F. David, A. Harris, et al. "Abstract P6-13-02: A phase 1 dose escalation study of RAD1901, an oral selective estrogen receptor degrader, in healthy postmenopausal women." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p6-13-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bonanni, Bernardo, Sara Gandini, Serena Mora, et al. "Abstract A59: A randomized, 3-arm placebo-controlled phase II presurgical trial of celecoxib or exemestane in postmenopausal breast cancer patients: preliminary results." In Abstracts: Frontiers in Cancer Prevention Research 2008. American Association for Cancer Research, 2008. http://dx.doi.org/10.1158/1940-6207.prev-08-a59.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ciruelos, E., P. Villagrasa, L. Paré, et al. "Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer." In Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-pd3-03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!